INDICATION: PONVORY® (ponesimod) is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.
Video Not Published
The below topics are covered by Dr Guger during the session:
Dr Michael Guger, Neurologist
Oberösterreichische Gesundheitsholding, GmbH Pyhrn-Eisenwurzen Klinikum, Steyr, Austria
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for how to report adverse reactions.
EAN, European Academy of Neurology; RMS, relapsing multiple sclerosis.